Applied DNA Sciences Inc (APDN)
0.1583
-0.01
(-4.06%)
USD |
NASDAQ |
Nov 21, 16:00
0.156
0.00 (0.00%)
After-Hours: 07:55
Applied DNA Sciences Revenue (Quarterly): 0.7975M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.7975M |
| March 31, 2024 | 0.9296M |
| December 31, 2023 | 0.8912M |
| September 30, 2023 | 0.7797M |
| June 30, 2023 | 2.917M |
| March 31, 2023 | 4.408M |
| December 31, 2022 | 5.263M |
| September 30, 2022 | 3.559M |
| June 30, 2022 | 4.296M |
| March 31, 2022 | 6.147M |
| December 31, 2021 | 4.166M |
| September 30, 2021 | 3.040M |
| June 30, 2021 | 1.700M |
| March 31, 2021 | 2.672M |
| December 31, 2020 | 1.616M |
| September 30, 2020 | 0.314M |
| June 30, 2020 | 0.4315M |
| March 31, 2020 | 0.5525M |
| December 31, 2019 | 0.6335M |
| September 30, 2019 | 1.673M |
| June 30, 2019 | 2.054M |
| March 31, 2019 | 0.7785M |
| December 31, 2018 | 0.8843M |
| September 30, 2018 | 1.195M |
| June 30, 2018 | 1.016M |
| Date | Value |
|---|---|
| March 31, 2018 | 1.044M |
| December 31, 2017 | 0.6477M |
| September 30, 2017 | 1.146M |
| June 30, 2017 | 1.797M |
| March 31, 2017 | 0.9054M |
| December 31, 2016 | 0.903M |
| September 30, 2016 | 1.636M |
| June 30, 2016 | 0.6529M |
| March 31, 2016 | 0.5733M |
| December 31, 2015 | 1.324M |
| September 30, 2015 | 3.980M |
| June 30, 2015 | 2.268M |
| March 31, 2015 | 1.519M |
| December 31, 2014 | 1.242M |
| September 30, 2014 | 0.6455M |
| June 30, 2014 | 0.8412M |
| March 31, 2014 | 0.6371M |
| December 31, 2013 | 0.5974M |
| September 30, 2013 | 0.7291M |
| June 30, 2013 | 0.6448M |
| March 31, 2013 | 0.3446M |
| December 31, 2012 | 0.3177M |
| September 30, 2012 | 0.2908M |
| June 30, 2012 | 0.5286M |
| March 31, 2012 | 0.5184M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.314M
Minimum
Sep 2020
6.147M
Maximum
Mar 2022
2.374M
Average
1.700M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Fonar Corp | 24.96M |
| XWELL Inc | 8.422M |
| ProPhase Labs Inc | 3.146M |
| Veracyte Inc | 115.86M |
| OncoCyte Corp | 0.115M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.880M |
| Total Expenses (Quarterly) | 4.144M |
| EPS Diluted (Quarterly) | 0.47 |
| Enterprise Value | -8.969M |
| Gross Profit Margin (Quarterly) | 30.75% |
| Earnings Yield | -7.57K% |
| Normalized Earnings Yield | -10658.74 |